We infected Kif5c−/− and B6 mice with 22 L scrapie and allowed them to reach terminal disease to determine whether absence of the KIF5C motor could alter survival times, neuropathology or the distribution of PrPSc in brain at the end stage of disease. This evidence concerns the gene KIF5C and scrapie.